Clinical Trials Arena on MSN
Tangram submits application to MHRA for TGM-312 Phase I/II clinical trial
Tangram Therapeutics has submitted a clinical trial application (CTA) to the Medicines and Healthcare products Regulatory ...
Tangram Therapeutics (‘Tangram’), a company committed to uniting computation and RNAi to make better medicines faster, today announced the submission of a Clinical Trial Application (CTA) to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback